Legal implications of pharmacogenomics regarding drug trials, drug labeling, and genetic testing for drug prescription: an international approach
Food and Drug Law Journal 2004; 59(4): 519-535
Drug Labeling; Genetic Testing; Labeling; Pharmacogenomics; Social Control of Science and Technology; Drugs and Drug Industry; Genetics, Molecular Biology and Microbiology; Human Experimentation Policy Guidelines / Institutional Review Boards; International and Political Dimensions of Biology and Medicine;
Showing items related by title, author, creator and subject.
Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products and Draft Guidances and Two Guidances for Industry on the Content and Format of Labeling for Human Prescription Drug and Biological Products; Final Rule and Notices Unknown author (United States. Food and Drug Administration [FDA], 2006-01-24)
Genetic Testing is Different [reviews of GENETIC TESTING FOR ALZHEIMER DISEASE: ETHICAL AND CLINICAL ISSUES, by Stephen G. Post and Peter J. Whitehouse and PROMOTING SAFE AND EFFECTIVE GENETIC TESTING IN THE UNITED STATES: PRINCIPLES AND RECOMMENDATIONS, by Task Force on Genetic Testing, NIH-DOE Working Group on Ethical, Legal, and Social Implications of Human Genome Research] Clayton, Ellen Wright (2001-04)
Legal Implications Regarding Self-Neglecting Community-Dwelling Adults: A Practical Approach for the Community Nurse in Ireland Ballard, Julianne (2010-03)This paper explores the current literature related to legal issues encountered by the public health nurse in Ireland in visiting clients exhibiting self-neglecting behavior. Nurses working in community settings where home ...